Follow
Sam Van der Tuin
Sam Van der Tuin
PhD student at LUMC, Leiden, The Netherlands
Verified email at lumc.nl
Title
Cited by
Cited by
Year
Exendin‐4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration
Y Wang, ET Parlevliet, JJ Geerling, SJL Van der Tuin, H Zhang, V Bieghs, ...
British journal of pharmacology 171 (3), 723-734, 2014
1242014
Expression of the polymeric Immunoglobulin Receptor (pIgR) in mucosal tissues of common carp (Cyprinus carpio L.)
J Rombout, SJL Van Der Tuin, G Yang, N Schopman, A Mroczek, ...
Fish & shellfish immunology 24 (5), 620-628, 2008
1032008
Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin
S Kühnast, SJL van der Tuin, JWA van der Hoorn, JB van Klinken, B Simic, ...
European heart journal 36 (1), 39-50, 2015
912015
Plasma cholesteryl ester transfer protein is predominantly derived from Kupffer cells
Y Wang, S van der Tuin, N Tjeerdema, AD van Dam, SS Rensen, ...
Hepatology 62 (6), 1710-1722, 2015
872015
Anacetrapib reduces (V) LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9 [S]
SJL van der Tuin, S Kühnast, JFP Berbée, L Verschuren, EJ Pieterman, ...
Journal of Lipid Research 56 (11), 2085-2093, 2015
382015
Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80+Clec4f+Vsig4+Ly6C Kupffer Cell Subsets
SJL van der Tuin, Z Li, JFP Berbée, I Verkouter, LE Ringnalda, AE Neele, ...
Journal of the American Heart Association 7 (6), e008105, 2018
352018
LPS reduces hepatic CETP expression by mature resident macrophages
Y Wang, Z Li, S Van Der Tuin, I Verkouter, J Van Klinken, A Groen, ...
Atherosclerosis 263, e8-e9, 2017
2017
Novel mechanistic insight in cholesteryl ester transfer protein production and pharmacological inhibition
SJL Van der Tuin
Leiden University, 2017
2017
Plasma CETP is derived from hepatic kupffer cells rather than adipose tissue
L Blauw, R de Mutsert, Y Wang, H Lamb, A de Roos, F Rosendaal, ...
Atherosclerosis 252, e244, 2016
2016
Anacetrapib Adds to the Antiatherogenic Effect of Atorvastatin, Mainly by Increasing the Clearance of Non-HDL Cholesterol
SJ van der Tuin, S Kuhnast, JW Van der Hoorn, JB van Klinken, B Simic, ...
Arteriosclerosis, Thrombosis, and Vascular Biology 34 (suppl_1), A246-A246, 2014
2014
PS13-7. Plasma cholesteryl ester transfer protein: a biomarker for hepatic macrophages
S van der Tuin, Y Wang, N Tjeerdema, V Bieghs, SS Rensen, J Fu, ...
Nederlands Tijdschrift voor Diabetologie 11, 195-195, 2013
2013
Anacetrapib Dose-dependently Decreases Atherosclerosis Development and Adds to the Beneficial Effects of Atorvastatin in APOE* 3Leiden. CETP Mice
S Kühnast, SJ van der Tuin, LM Havekes, K Willems van Dijk, ...
Arteriosclerosis, Thrombosis, and Vascular Biology 33 (suppl_1), A69-A69, 2013
2013
LisT oF PUBLicATioNs (FULL PAPers)
Y Wang, SJL Van der Tuin, N Tjeerdema, V Bieghs, SS Rensen, J Fu, ...
Novel modulators of lipoprotein metabolism, 237, 2013
2013
PS16-81. Chronic niacin treatment of ApoE* 3Leiden-CETP mice results in impaired insulin mediated repression of lipolysis in isolated adipocytes
M Heemskerk, S van den Berg, V van Harmelen, JB van Klinken, ...
Nederlands Tijdschrift voor Diabetologie 9 (3), 146-146, 2011
2011
The system can't perform the operation now. Try again later.
Articles 1–14